8
sphygmomanometers.
11. Informaonregardingpotenalelectromagnecorother
interferencebetweenthebloodpressuremonitorandotherdevices
togetherwithadviceregardingavoidanceofsuchinterference
pleaseseepartELECTROMAGNETICCOMPATIBILITYINFORMATION.
12. IfIrregularHeartbeat(IHB)broughtonbycommonarrhythmias
isdetectedintheprocedureofbloodpressuremeasurement,
asignalwillbedisplayed.Underthiscondion,theElectronic
Sphygmomanometercankeepfuncon,buttheresultsmaynotbe
accurate,it’ssuggestedthatyouconsultwithyourphysicianfor
accurateassessment.
Thereare2condionsunderwhichthesignalofIHBwillbe
displayed:
1) Thecoecientofvariaon(CV)ofpulseperiod>25%.
2) Thedierenceofadjacentpulseperiod≥0.14s,andthenumber
ofsuchpulsetakesmorethan53percentageofthetotal
numberofpulse.
13. Pleasedonotuseacuotherthansuppliedbythemanufacturer,
otherwiseitmaybringbiocompablehazardandmightresultin
measurementerrors.
14. Themonitormightnotmeetitsperformancespecicaonsor
causesafetyhazardifstoredorusedoutsidethespecied
temperatureandhumidityrangesinspecicaons.
15. Pleasedonotsharethecuwithaninfecvepersontoavoid
cross-infecon.
16. Thisequipmenthasbeentestedandfoundtocomplywiththelimits
foraClassBdigitaldevice,pursuanttopart15oftheFCCRules.
Theselimitsaredesignedtoprovidereasonableproteconagainst
harmfulinterferenceinaresidenalinstallaon.Thisequipment
generates,usesandcanradiateradiofrequencyenergyand,if
notinstalledandusedinaccordancewiththeinstrucons,may
causeharmfulinterferencetoradiocommunicaons.However,
thereisnoguaranteethatinterferencewillnotoccurinaparcular
installaon.Ifthisequipmentdoescauseharmfulinterference
MX86005 - IFU - 11.2020.indd 8MX86005 - IFU - 11.2020.indd 8 2020/12/14 16:372020/12/14 16:37